The SOUL study showed that adding oral semaglutide to standard care reduces the risk of major adverse cardiovascular events (MACE) by 14% in patients with type 2 diabetes and established cardiovascular or kidney disease
Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
After your plan is set, you can integrate GLP-1 care with body-contouring, skin-tightening, and K-Beauty facials to match your visible results to your changing body, as well as memberships that bundle visits, injections, and follow-ups
Initially administered at a low dose, tirzepatides dosage is gradually increased, with patients typically beginning to notice benefits within a month as they reach the full dosage
These reports have increased alongside the dramatic rise in GLP-1 prescribing for weight management, where higher doses and more pronounced weight loss may contribute to metabolic changes that affect muscle function
Semaglutide has a possible risk of thyroid tumor as well as cancer